Status:
COMPLETED
Cost Talk: Discussing Cancer Care Costs
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
Robert Wood Johnson Foundation
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate whether an encounter decision aid (used during a consultation) containing cost information about options, combined with clinician training about cost discus...
Detailed Description
The study will use a stepped wedge design to evaluate the encounter decision aid. Each participating urologic surgeon will begin in the usual care arm of the study. Subsequently, the surgeons will be ...
Eligibility Criteria
Inclusion
- At least 18 years of age
- Visiting a participating urologist/urologic surgeon to discuss treatment options
- Slow growing prostate cancer defined as Gleason score of 6 or 7 (3+4) and/or PSA (prostate-specific antigen) level less than 10ng/ml or at surgeon's discretion
- Must be patients of one of the participating providers
Exclusion
- Patients who cannot give informed consent due to cognitive or emotional barriers
Key Trial Info
Start Date :
June 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2022
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT04397016
Start Date
June 12 2020
End Date
July 2 2022
Last Update
September 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110